Publications
-
Patient-specific forecasting of post-radiotherapy prostate-specific antigen kinetics enables early prediction of biochemical relapseG. Lorenzo, N. di Muzio, C. L. Deantoni, C. Cozzarini, A. Fodor, A. Briganti, F. Montorsi, V. M. Pérez-García, H. Gómez, A. RealiiScience 25, 105430 (2022)
-
Mechanistic modelling of prostate-specific antigen dynamics shows potential for personalized prediction of radiation therapy outcomeG. Lorenzo, V.M. Pérez-García, Alfonso Mariño, L.A. Pérez Romasanta, Alessandro Reali, H. GómezJournal of the Royal Society Interface 20190195 (2019)
Collaborators
Work in this field is done in collaboration with applied mathematicians, Guillermo Lorenzo (Oden Institute for Computational Oncology, Texas, USA), Héctor Gómez (Purdue University, USA) and Alessandro Reali (University of Pisa, Italy) and also with radiation oncologists: Dr. Luis Pérez Romasanta (Hospital U. De Salamanca, Spain), Dr. Nadia di Muzio, and other clinicians at San Raffaele Hospital (Italy), between others. The optimal use of theranostic tools in prostate cancer is developed with Dr Babak Saboury (NIH), Bethesda, USA.